Taiwan · Delayed Price · Currency is TWD Dexin Statistics
Total Valuation
Dexin has a market cap or net worth of TWD 1.04 billion. The enterprise value is 882.79 million.
| Market Cap | 1.04B |
| Enterprise Value | 882.79M |
Important Dates
The next estimated earnings date is Wednesday, November 11, 2026.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Dexin has 46.07 million shares outstanding. The number of shares has increased by 14.38% in one year.
| Current Share Class | 46.07M |
| Shares Outstanding | 46.07M |
| Shares Change (YoY) | +14.38% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 10.29% |
| Owned by Institutions (%) | n/a |
| Float | 27.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.56 |
| PB Ratio | 3.40 |
| P/TBV Ratio | 3.52 |
| P/FCF Ratio | 17.51 |
| P/OCF Ratio | 16.52 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 14.85 |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.11 |
| Quick Ratio | 1.47 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.86 |
| Interest Coverage | -21.67 |
Financial Efficiency
Return on equity (ROE) is -18.56% and return on invested capital (ROIC) is -38.96%.
| Return on Equity (ROE) | -18.56% |
| Return on Assets (ROA) | -7.60% |
| Return on Invested Capital (ROIC) | -38.96% |
| Return on Capital Employed (ROCE) | -17.87% |
| Weighted Average Cost of Capital (WACC) | 3.73% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.78 |
| Inventory Turnover | 4.57 |
Taxes
In the past 12 months, Dexin has paid 8.13 million in taxes.
| Income Tax | 8.13M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.52% in the last 52 weeks. The beta is -0.10, so Dexin's price volatility has been lower than the market average.
| Beta (5Y) | -0.10 |
| 52-Week Price Change | +33.52% |
| 50-Day Moving Average | 21.50 |
| 200-Day Moving Average | 24.78 |
| Relative Strength Index (RSI) | 58.12 |
| Average Volume (20 Days) | 140,872 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dexin had revenue of TWD 406.85 million and -54.85 million in losses. Loss per share was -1.20.
| Revenue | 406.85M |
| Gross Profit | 55.19M |
| Operating Income | -63.86M |
| Pretax Income | -46.72M |
| Net Income | -54.85M |
| EBITDA | -47.62M |
| EBIT | -63.86M |
| Loss Per Share | -1.20 |
Balance Sheet
The company has 209.72 million in cash and 51.31 million in debt, with a net cash position of 158.42 million or 3.44 per share.
| Cash & Cash Equivalents | 209.72M |
| Total Debt | 51.31M |
| Net Cash | 158.42M |
| Net Cash Per Share | 3.44 |
| Equity (Book Value) | 306.44M |
| Book Value Per Share | 6.65 |
| Working Capital | 203.31M |
Cash Flow
In the last 12 months, operating cash flow was 63.02 million and capital expenditures -3.57 million, giving a free cash flow of 59.46 million.
| Operating Cash Flow | 63.02M |
| Capital Expenditures | -3.57M |
| Depreciation & Amortization | 16.24M |
| Net Borrowing | -12.00M |
| Free Cash Flow | 59.46M |
| FCF Per Share | 1.29 |
Margins
Gross margin is 13.57%, with operating and profit margins of -15.70% and -13.48%.
| Gross Margin | 13.57% |
| Operating Margin | -15.70% |
| Pretax Margin | -11.48% |
| Profit Margin | -13.48% |
| EBITDA Margin | -11.70% |
| EBIT Margin | -15.70% |
| FCF Margin | 14.61% |
Dividends & Yields
Dexin does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.38% |
| Shareholder Yield | -14.38% |
| Earnings Yield | -5.27% |
| FCF Yield | 5.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 30, 2022. It was a forward split with a ratio of 1.04.
| Last Split Date | Aug 30, 2022 |
| Split Type | Forward |
| Split Ratio | 1.04 |
Scores
Dexin has an Altman Z-Score of 2.8 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.8 |
| Piotroski F-Score | 3 |